Overview
Rexulti is a prescription drug approved by the Food and Drug Administration (FDA) as an adjunctive (add-on) therapy to antidepressants for treating major depressive disorder. Rexulti is also known by its drug… read more
Overview
Zurzuvae is approved by the U.S. Food and Drug Administration (FDA) to treat postpartum depression in adults. It’s prescribed for people experiencing depression after childbirth. Zurzuvae can be taken by itself…
The Zulresso brand name has been discontinued in the U.S.
Overview
Zulresso is approved by the U.S. Food and Drug Administration (FDA) for the treatment of postpartum depression (PPD) in people 15 and older. As of July…